0
Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO market gathers momentum and outrides tariff worries.
The shares opened at $28 and went as high as $31.5, signaling robust investor appetite for companies leveraging artificial intelligence for healthcare.
Heartflow sold about 16.67 million shares at $19 each in its IPO on Thursday, raising $316.7 million.
The Bain Capital-backed company’s debut comes as expectations of a softer trade policy and lower interest rates boost investor…
